Value investor Guy Spier said he has been diagnosed with glioblastoma during an interview on CNBC Television this Friday [1].

The revelation marks a significant shift for the Warren Buffett disciple, who is now pivoting his focus toward rare-disease research and personal legacy over financial gain [1, 2].

Speaking with Becky Quick, Spier said the diagnosis led him to reevaluate his life and the role of wealth in the face of a terminal illness [1, 3]. He said the experience has forced him to rethink his priorities, noting that the accumulation of money becomes secondary to family and time [1, 3].

Spier spoke about the emotional toll of the disease and the grief associated with missing future milestones. "I'm grieving that I won't maybe see my grandchildren ever, or I won't see my children get married, or I won't see my children graduate from university," Spier said [3]. "Who cares about money at that point?"

As a prominent figure in the value investing community, Spier has spent his career adhering to the principles of long-term growth and fundamental analysis. However, he said the reality of his health condition has shifted his perspective on what constitutes a meaningful investment of his remaining time [1, 2].

Spier said his focus has moved toward supporting research for rare diseases, a cause that aligns with his current medical struggle [1, 2]. He said the process of accepting the diagnosis is a way to find clarity on how to spend his final years with his family [3].

“Who cares about money at that point?”

The public disclosure by a high-profile financier like Spier highlights the intersection of wealth management and mortality. By shifting his focus from capital accumulation to rare-disease research, Spier is applying the 'value' framework to human life and medical advancement rather than stock portfolios.